CervoMed Secures $10 Million to Advance Brain Disease Pipeline
BOSTON, June 18, 2026 CervoMed Inc., a clinical-stage biotechnology company focused on developing therapies for age-related neurological disorders, has...
neuroscience research
Advertisement
Optimi Health Launches Standardized Psilocybin Microdose Capsules for Clinical Research
VANCOUVER, British Columbia, June 16, 2026 Optimi Health Corp. has announced the commercial production of two new standardized microdose...
Tempus AI and Bristol Myers Squibb Expand AI Clinical Trial Partnership
CHICAGO, Illinois, May 2026 Tempus AI announced an expanded strategic collaboration with Bristol Myers Squibb aimed at improving the...
NIH Awards $1.9M to RFU for Neurological Disease Research
North Chicago, Illinois, January 20, 2026 — A researcher at Rosalind Franklin University of Medicine and Science (RFU) has...
NIH Backs RFU Research on Social Deficits in Schizophrenia, ASD
December 18, 2025 | North Chicago, Illinois — Rosalind Franklin University of Medicine and Science has secured $1.73 million...
Advertisement
